Key facts
- Ananya Health’s last known valuation is $880K (Sep 2021).
- It has raised $570K across 1 recorded rounds; the latest was Seed Round ($404K) in Mar 2025.
- Notable investors include Y Combinator, Creative Destruction Lab, Fourthwave, EHA Ventures, National Cancer Institute — 6 tracked in total.
- Ananya Health has filed 2 Form Ds with the SEC since 2025, most recently May 2026 ($404K sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Ananya Health
Funding rounds
1 roundsAbout Ananya Health
Developer of a portable cervical cryoablation device designed to treat pre-cancerous cervical lesions at the point of diagnosis and prevent the onset of cervical cancer. The company's portable self-contained device can deliver cryotherapy even in clinics without regular access to power, enabling health practitioners to treat women for precancerous lesions effectively.
- Sector
- Healthcare
- HQ
- Oakland, CA, United States
- Founded
- 2020
- Employees
- 9
- Website
- ananya.health/
- Ownership
- Privately Held (backing)
Ananya Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ananya Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ananya Health in its N-PORT filings yet. We sweep new filings monthly.